Risk stratification for early-onset fetal growth restriction in women with abnormal serum biomarkers: a retrospective cohort study
Abstract Abnormal maternal serum biomarkers (AMSB), identified through the aneuploidy screening programme, are frequent incidental findings in pregnancy. They are associated with fetal growth restriction (FGR), but previous studies have not examined whether this association is with early-onset (<...
Enregistré dans:
Auteurs principaux: | L. Ormesher, L. Warrander, Y. Liu, S. Thomas, L. Simcox, G. C. S. Smith, J. E. Myers, E. D. Johnstone |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/44e3d63be3224d5aa0a7a0b6bdae4348 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction
par: Tu’uhevaha J. Kaitu’u-Lino, et autres
Publié: (2020) -
Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
par: Kamil Borkowski, et autres
Publié: (2021) -
Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers
par: Maya H Buch, et autres
Publié: (2021) -
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
par: Lewis J. Renshall, et autres
Publié: (2021) -
Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis
par: Bo Yang, et autres
Publié: (2021)